SCHEMBL3783933

SCHEMBL3783933

NOB(O)c1cc(C(=O)c2ccccc2)cc(C(=O)c2ccccc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 1/20 0.48
PBRM1 Q86U86 1/20 0.44
SRD5A2 P31213 1/20 0.42
CTSL P07711 2/20 0.41
CTSK P43235 1/20 0.41
STS P08842 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
ELANE P08246 1/20 0.40
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28154506 0.86 ALDH1A1 (0.52) ATMTDP1L3MBTL1ALDH1A1PBRM1
SCHEMBL3783947 0.79 KDM4E (0.46) ATMTDP1L3MBTL1ALDH1A1MEN1
SCHEMBL133982 0.77 ATM (0.84) ATMTDP1L3MBTL1ALDH1A1PBRM1
SCHEMBL13045507 0.77 ATM (0.84) ATMTDP1L3MBTL1ALDH1A1PBRM1
SCHEMBL3349765 0.77 ATM (0.84) ATMTDP1L3MBTL1ALDH1A1PBRM1
SCHEMBL3790216 0.74 ATM (0.46) ATMTDP1L3MBTL1ALDH1A1PBRM1
SCHEMBL3791149 0.74 ATM (0.46) ATMTDP1L3MBTL1ALDH1A1PBRM1
SCHEMBL56106 0.72 TRPV6 (0.50) TDP1ALDH1A1MEN1KMT2A
SCHEMBL134024 0.72 ATM (0.95) ATMTDP1L3MBTL1ALDH1A1PBRM1
SCHEMBL134300 0.72 ATM (0.95) ATMTDP1L3MBTL1ALDH1A1PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ATM 3506/4885TDP1 4196/4885L3MBTL1 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.